Monopar Therapeutics' mission is to acquire, develop and commercialize promising oncology product candidates that address the unmet medical needs of cancer patients.

Monopar is building a drug development pipeline through the licensing or acquisition of oncology therapeutics at the late preclinical through advanced clinical development stage that have demonstrated good antitumor efficacy and safety.

For inquiries about a potential partnership, collaboration, or licensing opportunity, please contact info@monopartx.com.